Inhibition of protein degradation induces apoptosis through a microtubule-associated protein 1 light chain 3-mediated activation of caspase-8 at intracellular membranes

Molecular and Cellular Biology

Volumn 31, Issue 15, 2011, Pages 3158-3170

  Pan, Ji An ^a   Ullman, Erica ^a   Dou, Zhixun ^a   Zong, Wei Xing ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CASPASE 8; MICROTUBULE ASSOCIATED PROTEIN 1; MICROTUBULE ASSOCIATED PROTEIN 1 LIGHT CHAIN 3; PROTEIN P62; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELLULAR DISTRIBUTION; CYTOSOL; DRUG MECHANISM; ENZYME ACTIVATION; HUMAN; HUMAN CELL; INTRACELLULAR MEMBRANE; MICROTUBULE; MOUSE; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FOLDING; PROTEIN HOMEOSTASIS; PROTEIN INTERACTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; APOPTOSIS; CASPASE 8; CELL LINE; CELL LINE, TUMOR; ENZYME ACTIVATION; FLUORESCENT ANTIBODY TECHNIQUE; HEAT-SHOCK PROTEINS; HUMANS; INTRACELLULAR MEMBRANES; LEUPEPTINS; MICE; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASMS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN FOLDING; PROTEIN MULTIMERIZATION; RNA INTERFERENCE; RNA, SMALL INTERFERING; UBIQUITINATION;

EID: 79960325950     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.05460-11     Document Type: Article

References (59)

1. Adams, J. 2004. The proteasome: a suitable antineoplastic target. Nat. Rev. Cancer 4:349-360.
2. Adams, J. M., and S. Cory. 2007. The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 26:1324-1337.
3. Allen, C., et al. 2008. Bortezomib-induced apoptosis with limited clinical response is accompanied by inhibition of canonical but not alternative nuclear factor-βB subunits in head and neck cancer. Clin. Cancer Res. 14:4175-4185.
4. Amaravadi, R. K., and C. B. Thompson. 2007. The roles of therapy-induced autophagy and necrosis in cancer treatment. Clin. Cancer Res. 13:7271-7279.
5. Ashkenazi, A., and V. M. Dixit. 1999. Apoptosis control by death and decoy receptors. Curr. Opin. Cell Biol. 11:255-260.
6. Axe, E. L., et al. 2008. Autophagosome formation from membrane compartments enriched in phosphatidylinositol 3-phosphate and dynamically connected to the endoplasmic reticulum. J. Cell Biol. 182:685-701.
7. Behrends, C., M. E. Sowa, S. P. Gygi, and J. W. Harper. 2010. Network organization of the human autophagy system. Nature 466:68-76.
8. Bjorkoy, G., et al. 2005. p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J. Cell Biol. 171:603-614.
9. Boatright, K. M., and G. S. Salvesen. 2003. Mechanisms of caspase activation. Curr. Opin. Cell Biol. 15:725-731.
10. Boldin, M. P., T. M. Goncharov, Y. V. Goltsev, and D. Wallach. 1996. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell 85:803-815.
11. Buchberger, A., B. Bukau, and T. Sommer. 2010. Protein quality control in the cytosol and the endoplasmic reticulum: brothers in arms. Mol. Cell 40:238-252.
12. Carew, J. S., S. T. Nawrocki, F. J. Giles, and J. L. Cleveland. 2008. Targeting autophagy: a novel anticancer strategy with therapeutic implications for imatinib resistance. Biologics 2:201-204.
13. Chen, K. F., et al. 2009. Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/Akt pathway. J. Biol. Chem. 284:11121-11133.
14. Chen, Z. H., et al. 2010. Autophagy protein microtubule-associated protein 1 light chain-3B (LC3B) activates extrinsic apoptosis during cigarette smokeinduced emphysema. Proc. Natl. Acad. Sci. U. S. A. 107:18880-18885.
15. Degenhardt, K., R. Sundararajan, T. Lindsten, C. Thompson, and E. White. 2002. Bax and Bak independently promote cytochrome c release from mitochondria. J. Biol. Chem. 277:14127-14134.
16. Ding, W. X., and X. M. Yin. 2008. Sorting, recognition and activation of the misfolded protein degradation pathways through macroautophagy and the proteasome. Autophagy 4:141-150.
17. Dou, Z., et al. 2010. The class IA phosphatidylinositol 3-kinase p110-β subunit is a positive regulator of autophagy. J. Cell Biol. 191:827-843.
18. Fehrenbacher, N., and M. Jaattela. 2005. Lysosomes as targets for cancer therapy. Cancer Res. 65:2993-2995.
19. Gonzalvez, F., et al. 2008. Cardiolipin provides an essential activating platform for caspase-8 on mitochondria. J. Cell Biol. 183:681-696.
20. Hailey, D. W., et al. 2010. Mitochondria supply membranes for autophagosome biogenesis during starvation. Cell 141:656-667.
21. Hainaut, P., and M. Hollstein. 2000. p53 and human cancer: the first ten thousand mutations. Adv. Cancer Res. 77:81-137.
22. Hayashi-Nishino, M., et al. 2009. A subdomain of the endoplasmic reticulum forms a cradle for autophagosome formation. Nat. Cell Biol. 11:1433-1437.
23. Hideshima, T., et al. 2003. Molecular mechanisms mediating antimyeloma activity of proteasome inhibitor PS-341. Blood 101:1530-1534.
24. Hightower, L. E. 1991. Heat shock, stress proteins, chaperones, and proteotoxicity. Cell 66:191-197.
25. Huang, H., S. Y. Choi, and M. A. Frohman. 2010. A quantitative assay for mitochondrial fusion using Renilla luciferase complementation. Mitochondrion 10:559-566.
26. Jin, Z., et al. 2009. Cullin3-based polyubiquitination and p62-dependent aggregation of caspase-8 mediate extrinsic apoptosis signaling. Cell 137:721-735.
27. Johnson, T. R., et al. 2003. The proteasome inhibitor PS-341 overcomes TRAIL resistance in Bax and caspase 9-negative or Bcl-xL overexpressing cells. Oncogene 22:4953-4963.
28. Kabeya, Y., et al. 2000. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J. 19:5720-5728.
29. Kabeya, Y., et al. 2004. LC3, GABARAP, and GATE16 localize to autophagosomal membrane depending on form-II formation. J. Cell Sci. 117(Pt. 13):2805-2812.
30. Kar, R., P. K. Singha, M. A. Venkatachalam, and P. Saikumar. 2009. A novel role for MAP1 LC3 in nonautophagic cytoplasmic vacuolation death of cancer cells. Oncogene 28:2556-2568.
31. Kawadler, H., M. A. Gantz, J. L. Riley, and X. Yang. 2008. The paracaspase MALT1 controls caspase-8 activation during lymphocyte proliferation. Mol. Cell 31:415-421.
32. Kirkin, V., D. G. McEwan, I. Novak, and I. Dikic. 2009. A role for ubiquitin in selective autophagy. Mol. Cell 34:259-269.
33. Komatsu, M., et al. 2007. Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice. Cell 131:1149-1163.
34. Korolchuk, V. I., A. Mansilla, F. M. Menzies, and D. C. Rubinsztein. 2009. Autophagy inhibition compromises degradation of ubiquitin-proteasome pathway substrates. Mol. Cell 33:517-527.
35. Korolchuk, V. I., F. M. Menzies, and D. C. Rubinsztein. 2010. Mechanisms of cross-talk between the ubiquitin-proteasome and autophagy-lysosome systems. FEBS Lett. 584:1393-1398.
36. Loehberg, C. R., et al. 2007. Ataxia telangiectasia-mutated and p53 are potential mediators of chloroquine-induced resistance to mammary carcinogenesis. Cancer Res. 67:12026-12033.
37. Lomonosova, E., J. Ryerse, and G. Chinnadurai. 2009. BAX/BAK-independent mitoptosis during cell death induced by proteasome inhibition? Mol. Cancer Res. 7:1268-1284.
38. Mathew, R., V. Karantza-Wadsworth, and E. White. 2007. Role of autophagy in cancer. Nat. Rev. Cancer 7:961-967.
39. Namgoong, G. M., et al. 2010. The prolyl isomerase Pin1 induces LC-3 expression and mediates tamoxifen resistance in breast cancer. J. Biol. Chem. 285:23829-23841.
40. Pandey, U. B., et al. 2007. HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS. Nature 447:859-863.
41. Pankiv, S., et al. 2007. p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J. Biol. Chem. 282:24131-24145.
42. Podar, K., et al. 2008. A pivotal role for Mcl-1 in Bortezomib-induced apoptosis. Oncogene 27:721-731.
43. Pop, C., P. Fitzgerald, D. R. Green, and G. S. Salvesen. 2007. Role of proteolysis in caspase-8 activation and stabilization. Biochemistry 46:4398-4407.
44. Puthalakath, H., et al. 2007. ER stress triggers apoptosis by activating BH3-only protein Bim. Cell 129:1337-1349.
45. Ravikumar, B., K. Moreau, L. Jahreiss, C. Puri, and D. C. Rubinsztein. 2010. Plasma membrane contributes to the formation of pre-autophagosomal structures. Nat. Cell Biol. 12:747-757.
46. Reimertz, C., D. Kogel, A. Rami, T. Chittenden, and J. H. Prehn. 2003. Gene expression during ER stress-induced apoptosis in neurons: induction of the BH3-only protein Bbc3/PUMA and activation of the mitochondrial apoptosis pathway. J. Cell Biol. 162:587-597.
47. Salvesen, G. S., and V. M. Dixit. 1999. Caspase activation: the inducedproximity model. Proc. Natl. Acad. Sci. U. S. A. 96:10964-10967.
48. Sanz, L., M. T. Diaz-Meco, H. Nakano, and J. Moscat. 2000. The atypical PKC-interacting protein p62 channels NF-κB activation by the IL-1-TRAF6 pathway. EMBO J. 19:1576-1586.
49. Shvets, E., E. Fass, R. Scherz-Shouval, and Z. Elazar. 2008. The N terminus and Phe52 residue of LC3 recruit p62/SQSTM1 into autophagosomes. J. Cell Sci. 121(Pt. 16):2685-2695.
50. Tinel, A., and J. Tschopp. 2004. The PIDDosome, a protein complex implicated in activation of caspase-2 in response to genotoxic stress. Science 304:843-846.
51. Kip1 expression through S-phase kinase protein 2 degradation in colorectal cancer. Cancer Res. 68:3379-3388.
52. Ullman, E., et al. 2008. Autophagy promotes necrosis in apoptosis-deficient cells in response to ER stress. Cell Death Differ. 15:422-425.
53. Ullman, E., J.-A. Pan, and W.-X. Zong. 2011. Squamous cell carcinoma antigen 1 promotes caspase-8-mediated apoptosis in response to endoplasmic reticulum stress while inhibiting necrosis induced by lysosomal injury. Mol. Cell. Biol. 31:2902-2919.
54. Voorhees, P. M., and R. Z. Orlowski. 2006. The proteasome and proteasome inhibitors in cancer therapy. Annu. Rev. Pharmacol. Toxicol. 46:189-213.
55. Wu, W. K., et al. 2010. Proteasome inhibition: a new therapeutic strategy to cancer treatment. Cancer Lett. 293:15-22.
56. Yan, X. B., et al. 2007. Caspase-8-dependent osteosarcoma cell apoptosis induced by proteasome inhibitor MG132. Cell Biol. Int. 31:1136-1143.
57. Yoshioka, A., et al. 2008. LC3, an autophagosome marker, is highly expressed in gastrointestinal cancers. Int. J. Oncol. 33:461-468.
58. Yu, J. W., P. D. Jeffrey, and Y. Shi. 2009. Mechanism of procaspase-8 activation by c-FLIPL. Proc. Natl. Acad. Sci. U. S. A. 106:8169-8174.
59. Zou, H., Y. Li, X. Liu, and X. Wang. 1999. An APAF-1 cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J. Biol. Chem. 274:11549-11556.